European Pharmaceutical Review

DECEMBER 19, 2022

The group adopted a positive opinion for Tremelimumab AstraZeneca (tremelimumab), to treat metastatic non-small cell lung cancer (NSCLC) in combination with Imfinzi (durvalumab) and platinum-based chemotherapy. The committee recommended to extend the use of original Spikevax vaccine and Spikevax bivalent Original/Omicron BA.1

Generic Medicine 104

Generic Medicine Vaccines Chemotherapy 104

European Pharmaceutical Review

APRIL 3, 2023

It is the eighth vaccine recommended in the European Union (EU) for COVID-19. The committee recommended granting a paediatric-use marketing authorisation (PUMA) for Pedmarqsi (sodium thiosulfate) for preventing ototoxicity induced by cisplatin chemotherapy. Cisplatin is a chemotherapy used to treat several types of cancer.

Vaccines 98

Vaccines Chemotherapy Generic Medicine 98

European Pharmaceutical Review

FEBRUARY 3, 2025

CHMP’s positive opinions for vaccines In addition, the human medicines committee recommended the vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine (21-valent)), as a preventative treatment for invasive disease and pneumonia caused by streptococcus pneumoniae bacteria in adults.

Generic Medicine 52

Generic Medicine Vaccines Chemotherapy Immunization 52